Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
D., Hansen, T., & Bain, S
Seek immediate care for severe abdominal pain (possible pancreatitis), vision changes, thyroid tumor signs (neck lump, hoarseness, trouble swallowing), or allergic reactions
Retatrutide, developed by Eli Lilly and currently in Phase 3 clinical trials, is a triple agonist simultaneously targeting GIP, GLP-1, and glucagon receptors
Med spas have capitalized on these functions by positioning B12 shots as a fast, accessible wellness upgrade often bundled with IV therapy, weight loss programs, or cosmetic treatment packages
Over a 52- to 68-week period, clinical trials have shown average weight loss ranging from 11% to 17% of initial body weight
Key Takeaway: The 5-day rule exists to ensure there is enough time between injections to prevent the medication from building up to uncomfortable levels in your system
